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ABSTRACT 
Background 
Worldwide, it is estimated that 264 million people meet the diagnostic criteria for anxiety 
conditions. Treatment regimens consist of cognitive and behavioural therapies. During the outbreak 
of the COVID-19 pandemic, treatment delivery relied heavily on telemedicine technologies which 
enabled remote access to patients via phone or video platforms. 
Objectives 
To identify, appraise and synthesise randomised controlled trials (RCTs) comparing telehealth to 
face-to-face delivery of care to individuals of any age or gender, diagnosed with anxiety disorders, 
and disorders with anxiety features. 
Design 
Systematic review and meta-analysis. 
Methods 
We searched three electronic databases, clinical trial registries and citing-cited references of 
included studies. 
Results 
A total of five RCTs were included; telehealth was conducted by video in three studies, and by phone 
in two. Overall, risk of bias was low to moderate for most domains. Outcomes related to obsessive 
compulsive disorder, anxiety, depression symptom severity, function, working alliance and 
satisfaction were comparable between the two modes of delivery across each follow-up time point 
(immediately post intervention, 3 months, 6 months and 12 months), with no significant differences 
reported (p>0.05). None of the trials reported on the costs of telehealth compared to face-to-face 
care. 
Conclusion 
Telehealth interventions appear to be as effective as conventional therapy delivered in-person for 
effectively treating anxiety and related conditions. There is a need for further high-quality trials to 
determine the effectiveness, acceptability, feasibility and cost-effectiveness of telehealth 
interventions for the management of anxiety disorders. 
Key words  
Telemedicine; telehealth; anxiety; cognitive behavioural therapy 
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Introduction  
Anxiety disorders are the most prevalent mental health conditions in Australia, currently 
experienced by one in seven Australians, and one in four will be affected in their lifetime.(1, 2) While 
anxiety disorders manifest in various forms, they all share features of excessive fear, anxiety, and 
related behavioural disruption, which impacts day-to-day life.(3) Although commonly comorbid with 
depressive disorders, other frequently comorbid conditions include substance use disorders and 
chronic physical illnesses.(4, 5) Worldwide, it is estimated that 264 million people meet the 
diagnostic criteria for anxiety conditions, which include generalised anxiety (GAD), social anxiety, 
specific phobias such as claustrophobia, and panic disorders. Anxiety is also a predominant feature 
in obsessive compulsive (OCD) and post-traumatic stress disorders (PTSD).(6) Although previously 
classed under anxiety disorders, the DSM-V has seen OCD and PTSD re-classified to their own 
disorder classes, obsessive-compulsive and related disorders and trauma- and stressor-related 
disorders, respectively.(3) Symptoms of anxiety disorders can impair functioning at home, in 
interpersonal relationships, in the workplace and community, and anxiety overall has been 
attributed as the 6th leading contributor to global disability by the World Health Organisation 
(WHO).(7). Access to effective therapy to treat these debilitating conditions is key to reducing the 
impairment from anxiety.   
 
Cognitive and behavioural therapies are considered to be the most effective psychosocial 
interventions for anxiety conditions, and are often associated with clinically meaningful 
improvements.(8) Several meta-analyses of well-controlled clinical trials provide evidence for the 
efficacy of cognitive behavioural therapy (CBT) for anxiety and anxiety-feature disorders including: 
GAD, social anxiety disorder, panic disorder, OCD and PTSD.(9, 10) Norton et al. further examined 
the efficacy of CBT across all anxiety conditions and reported that treatments using CBT techniques 
showed significantly larger treatment effect sizes than no treatment or placebo across all anxiety 
disorders.(11) Telemedicine technologies enable these effective therapies to be delivered to patients 
remotely via phone or video platforms. 
 
During the rapid spread of COVID-19, telehealth became a pivotal tool for medical treatment, 
facilitating the consistent provision of healthcare during a time when face-to-face contact is 
restricted.(12) Within mental health, the widespread availability of telehealth is particularly 
important given the increased levels of psychological distress related to the exceptional 
circumstances of the pandemic i.e. job losses, illness, death of friends or family, social distancing and 
isolation etc.(12) Fortney et al. described advantages of telehealth over face-to-face care, including 
reduced geographic, physical or time-related constraints for patients, potential cost savings to the 
health-care system, and enhanced opportunities for collaborative care, although this was amongst 
patients with depression, not anxiety conditions.(13) Fletcher et al. also examined the comparative 
effectiveness of face-to-face therapies versus video delivery for mental health patients, and found 
similar efficacy across the two therapy mediums.(14) However, these reviews were unable to 
conduct meta-analyses.(14) To gain fuller insight into the relative effectiveness of telehealth versus 
face-to-face services for the treatment of anxiety disorders, we conducted this systematic review, 
aiming to find, appraise and synthesise RCTs that have compared the clinical and financial impact of 
telehealth and face-to-face psychological therapies in children, adolescents and adults with anxiety 
disorders, and disorders with anxiety features. 
Methods  
This systematic review is reported following the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) statement (15) and the review protocol was developed prospectively. 
Minor deviations from the protocol are reported in the relevant methods section. 
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Inclusion and exclusion criteria 
Study design 
We included randomised controlled trials (RCTs) of any design (e.g., parallel, cluster, crossover, 
factorial, or mixed), which included more than 10 patients. We excluded all other study designs, such 
as: controlled non-randomised trials, qualitative studies, and observational studies (cohort, case-
control, cross-sectional, case series, case reports), as well as reviews (e.g., systematic, literature, 
scoping, etc.)  
 
Participants  
We included studies with people of any age or gender that were diagnosed with any type of anxiety 
disorder including: GAD, panic disorders, specific phobias, social anxiety. Although no longer 
considered an anxiety disorder in the DSM-V, we also included studies of patients with OCD, since 
the disorder has strong anxiety features and is often treated with similar psychotherapies. Although 
PTSD and depression were within scope of this review, there was enough literature to conduct a 
separate systematic reviews for those conditions (under review). Studies involving hospital patients 
(e.g., explicitly identified as taking place in hospital wards, or with patients shortly post-discharge) or 
those consulting a specialist (i.e., psychiatrist) were excluded. Studies in hospital discharged patient 
populations that explicitly identified provision of therapy by a psychologist, therapist, 
psychotherapist or counsellor, however, were included. 
 
Interventions 
We included studies of interventions involving standard care psychological therapies for anxiety and 
related conditions, such as exposure therapy, cognitive behavioural therapy, family therapy, and 
other related therapies. Studies examining novel treatments for anxiety conditions were not 
included. Therapy had to be provided synchronously (i.e., live) – studies providing asynchronous 
therapies (e.g., via email, SMS, etc.) were excluded.  
 
Comparators 
We included studies with an equivalent face-to-face comparator or telehealth comparator (i.e., 
video intervention with telephone comparator), providing the same therapy as the intervention 
group, that was identical or comparable in dose, duration, and frequency. Any comparator that was 
a wait-list control, or clinically inequivalent active comparator was excluded. 
 
Outcomes (primary, secondary) 
Studies were included if they reported on our primary outcomes of interest, comprising OCD severity 
and anxiety outcomes, such as DASS-A etc. Studies were also eligible if they reported on depression 
and function outcomes as well as working alliance inventory and satisfaction.  
 
Scales used to measure outcomes of interest 
 
- OCD Outcomes 
This outcome assessed results obtained from three OCD severity scales: YBOCS, CY-BOCS 
and the OCD CSR.   
The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is a 10-item scale, administered by 
health care providers and is designed to rate the severity of OCD symptoms, not establish a 
diagnosis. The items are scored on a four-point scale ranging from ‘no symptoms’ (0) to 
‘extreme symptoms’ (4). Scores of 0-7 are sub-clinical, and whereas higher scores of 32-40 
are classified as extremely severe symptoms of OCD.(16) 
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The Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) is a 10-item questionnaire 
adapted from the adult scale, and is designed to rate the severity of OCD symptoms in 
children and teenagers aged 6 to 17 years. The scoring is the same as per the adult 
questionnaire; the higher the score, the more severe the symptoms.(17) 
The clinical severity rating (CSR) was involves the completion of a diagnostic interview for 
OCD: the Anxiety Disorders Interview Schedule for Children and Parents for DSM–IV (ADIS-
IV), after which a CSR is assigned by a clinician.(18) CSRs range from 0-8 where 4 indicates 
that the DSM diagnostic criteria is met, and the higher the score, the more severe the 
condition.   
 
- Anxiety outcomes 
The DASS is a set of three self-report scales designed to measure the negative emotional 
states of depression, anxiety and stress. The anxiety subscale (DASS-A) contains 14 items 
and assesses autonomic arousal, skeletal muscle effects, situational anxiety, and subjective 
experience of anxious affect.(19) Patients self-rate themselves 0 to 3 on a 4-point scale, 
ranging from ‘did not apply to me at all, never’ (0) to ‘applied to me very much, or most of 
the time’ (3). A score of 0-3 in the anxiety subscale is considered normal, whereas scores 8 – 
10+ are considered severe to extremely severe.(20) 
 
- Depression outcomes  
Depression outcomes were measured using three scales across three studies. The Beck 
Depression Inventory (BDI) a 21-item, self-report rating inventory, was utilised by Lovell et 
al. and aims to measure depression symptoms and severity in persons ages ≥13 years.(21) A 
4‐point scale indicates degree of severity; items are rated from 0 (not at all) to 3 (extreme 
form of each symptom), and there are no arbitrary cut-off scores to classify different 
degrees of depression; the higher the score, the more severe form of depression.(21) The 
BDI-Y scale, adapted for use in children and teenagers aged 7 – 18 years old, is a 20-item 
self-report measure to assess symptom severity of depression. Patients describe how 
frequently a statement has been true for them over the past two weeks on a three-point 
scale - items are rated from 0 (Never) to 3 (Always).(22) The higher the score, the higher the 
severity of depression assessed.  
The DASS is a set of three self-report scales designed to measure the negative emotional 
states of depression, anxiety and stress. The depression subscale (DASS-D) contains 14 items 
and assesses dysphoria, hopelessness, devaluation of life, self-deprecation, lack of 
interest/involvement, anhedonia, and inertia.(19) Patients self-rate themselves 0 to 3 on a 4-
point scale, ranging from ‘did not apply to me at all, never’ (0) to ‘applied to me very much, 
or most of the time’ (3). A score of 0-4 in the depression subscale is considered normal, 
whereas scores 11 – 14+ are considered severe to extremely severe.(20)  
- Function  
Data for this outcome was obtained from the Children’s Global Assessment Scale (CGAS), 
which is a rating of functioning aimed specifically at children aged 6-17 years.(23) The scale 
assesses a patients level of psychological and social functioning, and a score between 1 and 
100 is assigned accordingly. A lower score (1-10) indicates extreme impairment, whereas a 
higher score (91 – 100) indicates a patient is doing very well.(23) 
 
- Working alliance inventory score 
The working alliance inventory (WAI) score evaluates the collaborative relationship between 
the health care provider and the patient. There are two types of WAI questionnaires – the 
full 36-item or the shortened 12-item questionnaire. Patients and health care providers rate 
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items on a 5-point Likert scale ranging from ‘rarely or never’ (1) to ‘always’ (5). Higher scores 
indicate a better therapeutic alliance.(24) 
- Client satisfaction scale  
The client satisfaction scale is a self-reported measure of satisfaction with health and human 
services. Patients assess each question on a 4-point Likert scale, ranging from dissatisfied (1) 
to very satisfied (4). A higher score indicates higher satisfaction.(25) 
 
Search strategy 
Electronic databases, including PubMed (MEDLINE), Embase, and CENTRAL via the Cochrane Library 
were searched for potentially relevant primary studies from inception until 18 November 2020. 
Clinical trial registries were also searched, including the WHO ICTRP and clinicaltrials.gov. The search 
string (Appendix 1) was translated for use in other databases using the Polyglot Search Translator 
and screening used the Disputatron feature of the systematic review accelerator.(26) The search 
strings were deliberately broad, as the present review was conducted as part of a series of 
systematic reviews on the effectiveness of telehealth compared to face to face for healthcare 
provision in primary care and allied care. 
 
Other searches 
A forward (citing) and backward (cited) citation search of the included studies was performed on the 
15th December 2020 to identify any further relevant studies. 
 
Restriction on publication type 
No restrictions by language or publication date were imposed. We included only those publications 
from randomised controlled trials that were published in full. We excluded publications available as 
abstract only (e.g., conference abstract) with no additional results information available (e.g., from a 
clinical trial registry record). 
 
Screening and Data extraction  
Paired review authors (NK, HG, RP, MC, AMS, JC, PG) independently screened the titles and abstracts 
for inclusion against the inclusion criteria. One author retrieved full-text (JC), and paired authors 
screened the full-texts for inclusion (NK, HG). Any disagreements were resolved by discussion, or 
reference to a third author. Three data extraction forms were used for extracting study information 
including: Table of Characteristics form, Primary and Secondary Outcomes data form, and Risk of 
Bias form. Data from included studies were extracted independently by two authors (NK, HG) into 
the data extraction forms and discrepancies were resolved by discussion or by reference to a third 
author. (see Box 1). 
 
Box 1. List of extracted information  
 
• Methods: Study authors, location, study design, duration of follow-up 
• Participants: n, age (mean), anxiety disorder diagnosis  
• Interventions: telehealth  
• Comparators: face-to-face 
• Primary and secondary outcomes: OCD severity, anxiety outcomes, depression outcomes, 
function, working alliance inventory, satisfaction  
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Risk of bias  
Risk of bias was assessed with the Cochrane Collaboration’s Risk of Bias tool 1.(27) We used the Risk 
of Bias Tool 1 rather than Tool 2, as the former allows for the assessment of biases arising from 
study funding and conflict of interest (under domain 7, other bias).Two authors (NK, HG) 
independently assessed: the method of random sequence generation and allocation concealment 
(selection bias), blinding of participants and personnel (performance bias), blinding of outcome 
assessment (detection bias), outcome reporting (attrition bias), selective reporting (reporting bias), 
and other bias (from funding or conflict of interest issues). Disagreements were resolved by 
discussion or a third assessor. For each item, risk was either ‘high’, ‘low’ or ‘unclear’.  
 
Statistical analysis  
Review Manager 5.4 was used to calculate the effect of interventions.(28) We used mean 
differences or standardised mean differences for continuous outcomes. We undertook meta-
analyses where data was appropriate to pool (when > 2 studies or comparisons reported the same 
outcome). We used a random effects model in anticipation of considerable heterogeneity.  
 
The individual was used as the unit of analysis, where possible. However, where data on the number 
of individuals with primary and secondary outcomes of interest was not available, we extracted the 
information as it was presented (e.g., mean scores). We did not contact investigators or study 
sponsors to provide missing data.  
 
We used the I2 statistic to measure heterogeneity among the included trials. As fewer than 10 
studies were included in the analysis, a funnel plot was not able to be created. Sub-group analyses 
were conducted by timepoint at which the outcome was reported.  
 
A pre-specified sensitivity analysis for including versus excluding studies with 3 or more domains 
rated at high risk of bias was not conducted, as no studies were rated at high risk of bias for 3 or 
more domains.  
Results  
Search results 
The electronic search yielded 5,423 references, supplemented with 119 references from forward 
and backward citations of the included studies and 126 from clinical trial registry search, resulting in 
3,904 records to screen after deduplication. Screening these on title and abstract excluded 3,887, 
leaving 17 articles for which we obtained full-text. Screening of these excluded another 12 to leave 5 
randomised controlled trials included in this systematic review. Reasons for exclusions are reported 
in Appendix 2.  
 
Characteristics of the five included studies are presented in Table 1. Two studies were conducted in 
the UK, and the remaining 3 studies were conducted in the USA, Australia and Canada, respectively. 
Three studies focused on OCD as the primary anxiety condition, one explored GAD and the final 
study examined a range of anxiety and mood disorders (including OCD). The types of therapies 
delivered were all CBT-based, and most were delivered as individual therapy sessions. Only one 
study reported the delivery of family-based CBT for young children diagnosed with OCD. Studies 
compared conventional therapy in clinic settings versus the home or clinic-based treatment rooms 
for telehealth interventions. Video medium was used for three studies, while phone was used for 2 
studies.  
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Additional records identified from 
forward/backward citation search  
(n = 119) 
Additional records identified from clinical trial 
registry search (n = 126) 
 
Records after duplicates removed 
(n = 3,904) 
Records screened 
(n = 3,904) 
Records excluded 
(n = 3,887) 
Full-text articles assessed for 
eligibility (n = 17) 
Full-text articles excluded, 
with reasons (see Appx 2) 
(n = 12) 
 
Studies included in 
qualitative synthesis 
(n = 5) 
Studies included in 
quantitative synthesis (meta-
analysis) 
(n = 5) 
Records identified through database 
searching 
(n = 5,423) 
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Table 1. Characteristics of included studies 
Author, 
year 











Ages n years 
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CBT Video, individual, on-






















CBT Phone, individual, via 
phone (not specified 






Canada Parallel None 148 (69 
telehealth, 79 
F2F) 
Adults (18 – 






F2F: 40 (16) 
CBT Video, individual, on-




F2F = face-to-face, OCD = Obsessive Compulsive Disorder, DSM = Diagnostic and Statistical Manual of Mental Disorders, GAD = Generalised Anxiety Disorder, FB-CBT = family based 
cognitive behavioural therapy - Freeman and Garcia program, CBT = cognitive behavioural therapy 
This is the peer reviewed version of the following article:   
Krzyżaniak, N., Greenwood, H., Scott, A., Peiris, R., Cardona, M., Clark, J., & Glasziou, P. P. (2021). The effectiveness of telehealth versus face-to face 
interventions for anxiety disorders: A systematic review and meta-analysis. Journal of Telemedicine and Telecare,  
which has been published in final form at https://doi.org/10.1177/1357633X211053738 
Risk of bias 
Overall, over 50% of studies adequately reported on random sequence generation, allocation 
concealment, incomplete outcome data, and selective reporting. The authors’ conflicts of interest 
and study funding were also satisfactorily described in most of the trials (assessed under the ‘other 
bias’ domain). Blinding of participants and personnel was at high risk of bias for 100% of studies due 
to the nature of the compared interventions, which precluded blinding. The blinding of outcome 
assessors was unclear for over 50% of studies. (See Figure 2)  
 
Figure 2: Risk of bias graph: review authors' judgements about each risk of bias item presented as 
percentages across all included studies. 
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Primary Outcomes:  
OCD outcomes 
 
Figure 3. Telehealth vs. F2F for Anxiety disorders: Severity of OCD symptoms (Y-BOCS, CY-BOCS and 
CSR scales) 
 
Three studies reported sufficient data for this outcome. (Figure 3) Data was categorised into four 
subgroups – immediately post treatment, 3-month, 6-month and 12-month follow up. Data from 
Comer et.al. was not analysed as means reflected model estimated values rather than raw means.  
There were no significant differences in OCD outcomes between telehealth and face-to-face therapy 
immediately post treatment (156 participants, MD 0.14 (95% CI -0.17 to 0.45, p = 0.38) or at any of 
the follow-up time points including: 3 months (124 participants, standardised mean difference: 0.05, 
95% CI -0.3 to 0.4, p = 0.78), 6 months (136 participants, standardised mean difference: 0.1, 95% CI -
0.24 to 0.44, p = 0.56), and at 12 months (52 participants, standardised mean difference: 0.34, 95% 
CI -0.21 to 0.89, p = 0.22).  
 
Anxiety outcomes 
Only one study explored the anxiety-specific component of the DASS-A scale.(31) There were no 
significant differences identified in the immediately post treatment period between groups (23 
participants, mean difference: -0.47, 95% CI -6.94 to 6.0, p = 0.66) or at the 1.5 month follow up (16 
participants, mean difference: -1.53, 95% CI -7.93 to 4.87, p = 0.66).   
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Figure 4. Telehealth vs. F2F for Anxiety disorders: Severity of depression symptoms (BDI, BDI-Y and 
DASS-D scales) 
 
Three studies provided data relevant to this outcome. (Figure 4) The data were divided into four pre-
specified groups. There were no significant differences in depression outcomes between telehealth 
and face-to-face therapy immediately post treatment (157 participants, standardised mean 
difference: -0.02 (95% CI -0.44 to 0.39, p = 0.91) or at any of the follow-up time points including: 1.5 
to 3 months (140 participants, standardised mean difference: -0.25, 95% CI -0.58 to 0.09, p = 0.15), 6 
months (116 participants, standardised mean difference: -0.19, 95% CI -0.67 to 0.29, P = 0.44), and 
at 12 months (52 participants, standardised mean difference: -0.2, 95% CI -0.74 to 0.35, P = 0.48). 
Moderately high heterogeneity was reported in the immediately post treatment subgroup (I² = 36%) 
and in the 6-month group (I² = 42%).  
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Function 
 
Figure 5. Telehealth vs. F2F for Anxiety disorders: assessment of function using the CGAS scale 
 
Two studies reported sufficient data for this outcome. (Figure 5) 
There were no significant differences in function outcomes between telehealth and face-to-face 
therapy immediately post treatment (88 participants, mean difference: -0.15 (95% CI -0.57 to 0.27, p 
= 0.49) or at any of the follow-up time points including: 3 months (61 participants, standardised 
mean difference: -0.08, 95% CI -0.59 to 0.42, p = 0.75), 6 months (71 participants, standardised 
mean difference: 0.11, 95% CI -0.35 to 0.58, p = 0.63), and at 12 months (52 participants, 
standardised mean difference: -0.18, 95% CI -0.73 to 0.36, p = 0.52). 
 
Working alliance inventory score  
Therapist working alliance score 
 
Figure 6. Telehealth vs. F2F for Anxiety disorders: Therapist working alliance inventory score  
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Three studies provided adequate data for this outcome from the perspective of the health care 
professional, involving a total of 161 participants. (Figure 6) We did not find evidence of a difference 
between the two treatments in this comparison, standardised mean difference was -0.02 (95% CI: -
0.33 to 0.29, p = 0.91).  
 
Client working alliance score 
 
Figure 7. Telehealth vs. F2F for Anxiety disorders: Client-reported working alliance inventory score  
 
For this outcome, we identified three relevant studies, with a total of 160 participants. (Figure 7) 
Comer et.al. reported mother working alliance score, which was included in the analysis as we 
considered the mother as a proxy client. This outcome had moderate levels of heterogeneity, I2 = 
53%. We did not find evidence of a difference between the two interventions, with a standardised 




Figure 8. Telehealth vs. F2F for Anxiety disorders: Client satisfaction scale 
 
Three studies provided adequate data for this outcome, involving 112 participants. Comer et.al. 
provided data on the mother’s satisfaction, which was included in the analysis as we considered the 
mother as a proxy client. We did not find evidence of a difference between the two groups, with a 
standardised mean difference of -0.27 (95% CI -0.65 to 0.1, p = 0.15).  
Discussion  
We identified 5 eligible randomised controlled trials (total of 340 participants) comparing 
psychotherapy delivered via telehealth versus face-to-face care for patients with anxiety and related 
conditions. Overall, the quality of the evidence was good, with risk of bias being low or unclear for 
most domains. The exception was high risk of bias for blinding of the intervention for participants or 
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health care providers, which was impossible given the nature of the interventions. Heterogeneity 
was low across all outcomes, except two time points for depression severity where there was 
moderate heterogeneity. Our review found no differences between telehealth and face-to-face 
psychotherapies for any outcomes; OCD, anxiety, or depression symptom severity, function, 
therapist- or client-reported working alliance or client satisfaction.  
 
These findings support previous research suggesting that psychotherapy delivered remotely may be 
as effective as conventional face-to-face therapy. Fletcher et al conducted a non-systematic 
literature review for the efficacy of video delivered therapy, which found that video to home 
treatment of mental health conditions offers a viable option for care access for patients, especially 
when there are logistical or other barriers to receiving in person care (14). Another systematic 
review by Coughtrey and Pistrang found that telephone-delivered psychotherapy may be as effective 
as face-to-face therapy for reducing symptoms of anxiety and depression.(34)  
 
The present review, with up-to-date data from randomised controlled trials adds weight to these 
previous findings that psychotherapy delivered remotely is as effective as face-to-face therapy for 
anxiety disorder treatment. These findings are particularly important in the current world climate, 
where effective alternatives to face-to-face are required for public health safety.(35) Key challenges 
during the pandemic of reducing person to person contact, whilst still ensuring continuity of care 
may be adequately addressed by telehealth treatment, at least in the instance of psychotherapy for 
anxiety and related conditions.  
 
While this review supports and extends previous research into the effectiveness of telehealth for 
anxiety conditions, we have identified some limitations to our findings. First, due to strict eligibility 
criteria, only five trials were includable in this review. Of these, four studies reported data for OCD 
patients, and only one focused on generalised anxiety disorder specifically. Since the inception of the 
DSM-V, OCD is no longer classed as an anxiety disorder and is now considered its own disorder 
class.(3) Given the anxiety pre-dominant nature of this disorder, overlapping psychotherapies used 
for treatment, and the paucity of evidence of telehealth for pure anxiety disorders, we justified 
including OCD as an anxiety-related condition for this review. While this choice allowed us to 
synthesise the evidence, it does limit the generalisability of the findings to all anxiety conditions. 
Further high-quality research across the wider scope of anxiety disorders is warranted to solidify 
these findings.  
 
Second, although we did not restrict inclusion by psychotherapy, all included studies used either CBT 
or graded exposure and response prevention therapy. Although these therapies are both effective 
and recommended treatments for anxiety and related conditions, other therapies such as 
mindfulness and interpersonal therapies are also often used.(36, 37) Our results are not 
generalisable beyond CBT and graded exposure and response prevention therapy. It may be 
beneficial to conduct trials assessing other psychotherapies used to treat anxiety and related 
conditions 
 
Despite these limits on generalisability, the strength of our review lies in its rigorous methodology. 
Our search methods were comprehensive, including multiple databases, forward and backward 
citation, and clinical trial registry search. We only included randomised controlled trials, which 
strengthens the conclusions drawn. Although only a small evidence base of five studies exists, these 
trials are worldwide (USA, UK, Canada and Australia), and with all age groups (children, adolescents 
and adults), so our findings can be broadly generalised to these settings and patient groups.  
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Conclusions 
Supported by advances in modern technology, telehealth has an important role in increasing access 
to mental health care. From the direct comparisons in this review, telehealth interventions appear to 
be as effective as conventional therapy delivered in-person for effectively treating anxiety and 
related conditions. While further randomised trials in a range of anxiety conditions and 
psychotherapies are warranted, the current evidence appears sufficient to promote the use of 
telehealth as an effective alternative to face-to-face care for the treatment of OCD, GAD and 
potentially other anxiety disorders treated using CBT and graded exposure/response prevention 
therapy.    
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Appendix 1: Search string 
 
Database searches 
PubMed Search run 18/11/2020 
("Telemedicine"[Mesh] OR "Videoconferencing"[Mesh] OR Telehealth[tiab] OR Telemedicine[tiab] 
OR Videoconferencing[tiab] OR ((Telephone[tiab]) AND (Consultation[tiab] OR face-to-face[tiab] OR 
in-person[tiab])) OR telephone-delivered[tiab]) 
AND 
("Primary Health Care"[Mesh] OR "General Practice"[Mesh] OR rehabilitation[sh] OR 
"Outpatients"[Mesh] OR "Speech Therapy"[Mesh] OR Outpatient[tiab] OR “Primary health”[tiab] OR 
“Primary care”[tiab] OR “General practice”[tiab] OR “General practices”[tiab] OR “General 
practitioners”[tiab] OR “General practitioner”[tiab] OR “Family practice”[tiab] OR Physician[tiab] OR 
Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR Therapist[tiab] OR Nurse[tiab] OR 
Nurses[tiab] OR Physiotherapist[tiab] OR Rehabilitation[tiab] OR Diabetes[tiab] OR Diabetic[tiab] OR 
Asthma[tiab] OR Depression[tiab] OR “Ïrritable bowel”[tiab] OR IBS[tiab] OR PTSD[tiab] OR “Chronic 
fatigue”[tiab]) 
AND 
((Face-to-face[tiab]) OR “Usual care”[tiab] OR Visits[tiab] OR Visit[tiab] OR In-person[tiab] OR “In 
person”[tiab] OR ((Clinic[tiab] OR Centre[tiab] OR Home[tiab]) AND (Based[tiab] OR Contact[tiab])) 
OR Conventional[tiab] OR “Practice-based”[tiab] OR “Practice based”[tiab] OR Traditional[tiab] OR 
“Standard care”[tiab] OR Homecare[tiab] OR ((Routine[tiab] OR Home[tiab]) AND (Care[tiab]))) 
AND 
("Delivery of Health Care"[Mesh] OR Delivery[tiab] OR Delivered[tiab] OR Via[tiab] OR 
Received[tiab]) 
AND 
("Treatment Outcome"[Mesh] OR "Patient Satisfaction"[Mesh] OR Therapy[sh] OR Diagnosis[sh] OR 
“Clinical outcomes”[tiab] OR Treatment[tiab] OR Diagnostic[tiab] OR Efficacy[tiab]) 
AND 
(Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR 
randomised[tiab] OR placebo[tiab] OR "drug therapy"[sh] OR randomly[tiab] OR trial[tiab] OR 
groups[tiab]) 
NOT  
(Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) 
NOT 
(“Case Reports”[pt] OR Editorial[pt] OR Letter[pt] OR Meta-Analysis[pt] OR “Observational 
Study”[pt] OR “Systematic Review”[pt] OR “Case Report”[ti] OR “Case series”[ti] OR Meta-
Analysis[ti] OR “Meta Analysis”[ti] OR “Systematic Review”[ti] OR “Systematic Literature Review”[ti] 
OR “Qualitative study”[ti] OR Protocol[ti]) 
 
CENTRAL via the Cochrane Library run 18/11/2020 
([mh Telemedicine] OR [mh Videoconferencing] OR Telehealth:ti,ab OR Telemedicine:ti,ab OR 
Videoconferencing:ti,ab OR ((Telephone:ti,ab) AND (Consultation:ti,ab OR “ face-to-face”:ti,ab OR 
“in person”:ti,ab)) OR “telephone delivered”:ti,ab) 
AND 
([mh "Primary Health Care"] OR [mh "General Practice"] OR [mh Outpatients] OR [mh "Speech 
Therapy"] OR Outpatient:ti,ab OR "Primary health":ti,ab OR "Primary care":ti,ab OR "General 
practice":ti,ab OR "General practices":ti,ab OR "General practitioners":ti,ab OR "General 
practitioner":ti,ab OR "Family practice":ti,ab OR Physician:ti,ab OR Physicians:ti,ab OR Clinician:ti,ab 
OR Clinicians:ti,ab OR Therapist:ti,ab OR Nurse:ti,ab OR Nurses:ti,ab OR Physiotherapist:ti,ab OR 
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Rehabilitation:ti,ab OR Diabetes:ti,ab OR Diabetic:ti,ab OR Asthma:ti,ab OR Depression:ti,ab OR 
"Ïrritable bowel":ti,ab OR IBS:ti,ab OR PTSD:ti,ab OR "Chronic fatigue":ti,ab) 
AND 
(("Face-to-face":ti,ab) OR "Usual care":ti,ab OR Visits:ti,ab OR Visit:ti,ab OR "In person":ti,ab OR 
((Clinic:ti,ab OR Centre:ti,ab OR Home:ti,ab) AND (Based:ti,ab OR Contact:ti,ab)) OR 
Conventional:ti,ab OR "Practice based":ti,ab OR Traditional:ti,ab OR "Standard care":ti,ab OR 
Homecare:ti,ab OR ((Routine:ti,ab OR Home:ti,ab) AND (Care:ti,ab))) 
AND 
([mh "Delivery of Health Care"] OR Delivery:ti,ab OR Delivered:ti,ab OR Via:ti,ab OR Received:ti,ab) 
AND 
([mh "Treatment Outcome"] OR [mh "Patient Satisfaction"] OR "Clinical outcomes":ti,ab OR 
Treatment:ti,ab OR Diagnostic:ti,ab OR Efficacy:ti,ab) 
 
Embase search run 18/11/2020 
('Telemedicine'/exp OR 'Videoconferencing'/exp OR Telehealth:ti,ab OR Telemedicine:ti,ab OR 
Videoconferencing:ti,ab OR ((Telephone:ti,ab) AND (Consultation:ti,ab OR face-to-face:ti,ab OR in-
person:ti,ab)) OR telephone-delivered:ti,ab) 
AND 
('Primary Health Care'/exp OR 'General Practice'/exp OR 'Outpatient'/exp OR 'Speech Therapy'/exp 
OR Outpatient:ti,ab OR "Primary health":ti,ab OR "Primary care":ti,ab OR "General practice":ti,ab OR 
"General practices":ti,ab OR "General practitioners":ti,ab OR "General practitioner":ti,ab OR "Family 
practice":ti,ab OR Physician:ti,ab OR Physicians:ti,ab OR Clinician:ti,ab OR Clinicians:ti,ab OR 
Therapist:ti,ab OR Nurse:ti,ab OR Nurses:ti,ab OR Physiotherapist:ti,ab OR Rehabilitation:ti,ab OR 
Diabetes:ti,ab OR Diabetic:ti,ab OR Asthma:ti,ab OR Depression:ti,ab OR "Ïrritable bowel":ti,ab OR 
IBS:ti,ab OR PTSD:ti,ab OR "Chronic fatigue":ti,ab) 
AND 
(("Face-to-face":ti,ab) OR "Usual care":ti,ab OR Visits:ti,ab OR Visit:ti,ab OR In-person:ti,ab OR "In 
person":ti,ab OR ((Clinic:ti,ab OR Centre:ti,ab OR Home:ti,ab) AND (Based:ti,ab OR Contact:ti,ab)) OR 
Conventional:ti,ab OR Practice-based:ti,ab OR "Practice based":ti,ab OR Traditional:ti,ab OR 
"Standard care":ti,ab OR Homecare:ti,ab OR ((Routine:ti,ab OR Home:ti,ab) AND (Care:ti,ab))) 
AND 
('health care delivery'/exp OR Delivery:ti,ab OR Delivered:ti,ab OR Via:ti,ab OR Received:ti,ab) 
AND 
('Treatment Outcome'/exp OR 'Patient Satisfaction'/exp OR "Clinical outcomes":ti,ab OR 
Treatment:ti,ab OR Diagnostic:ti,ab OR Efficacy:ti,ab) 
AND 
(random* OR factorial OR crossover OR placebo OR blind OR blinded OR assign OR assigned OR 
allocate OR allocated OR 'crossover procedure'/exp OR 'double-blind procedure'/exp OR 
'randomized controlled trial'/exp OR 'single-blind procedure'/exp NOT ('animal'/exp NOT 
('animal'/exp AND 'human'/exp))) 
 AND [embase]/lim 
 
Clinical trial registry searches 
Clinicaltrials.gov (searched 25/3/2021) 
Intervention field: (Telemedicine OR Videoconferencing OR Telephone OR Telehealth) AND (“Usual 
care” OR “Standard care” OR Face-to-face OR Face-to-face”)  
Condition or disease field: Anxiety 
 
WHO ICTRP (searched 25/3/2021) 
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Telemedicine AND Anxiety OR Telehealth AND Anxiety OR Videoconferencing AND Anxiety  
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Appendix 2: Table of Excluded Studies 
 
 Reference Reason for exclusion  
Forward and Backward Citation Analysis 
1 Bouchard, S., et al. (2004). "Delivering Cognitive-Behavior Therapy for Panic 
Disorder with Agoraphobia in Videoconference." Telemedicine Journal and e-
Health 10(1): 13-25. 
Study design  
 
2 Burgess, M., et al. (2012). "Cognitive behaviour therapy for chronic fatigue 
syndrome in adults: Face-to-face versus telephone treatment - A randomized 
controlled trial." Behavioural and Cognitive Psychotherapy 40(2): 175-191. 
Not comparable 
interventions  
3 Choi, N. G., et al. (2014). "Telehealth problem-solving therapy for depressed 
low-income homebound older adults." American Journal of Geriatric Psychiatry 
22(3): 263-271. 
Study outcomes  
4 Day, S. X. and P. L. Schneider (2002). "Psychotherapy using distance technology: 
A comparison of face-to-face, video, and audio treatment." Journal of 
Counseling Psychology 49(4): 499-503. 
Study outcomes  
5 Frueh, B. C., et al. (2007). "A randomized trial of telepsychiatry for post-
traumatic stress disorder." Journal of Telemedicine and Telecare 13(3): 142-
147. 
Study outcomes  
6 Mitchell, J. E., et al. (2008). "A randomized trial comparing the efficacy of 
cognitive-behavioral therapy for bulimia nervosa delivered via telemedicine 
versus face-to-face." Behaviour Research and Therapy 46(5): 581-592. 
Study outcomes  
7 Rowa, K., et al. (2007). "Office-based vs. home-based behavioral treatment for 
obsessive-compulsive disorder: A preliminary study." Behaviour Research and 
Therapy 45(8): 1883-1892. 
Study design  
8 Ruskin, P. E., et al. (2004). "Treatment outcomes in depression: Comparison of 
remote treatment through telepsychiatry to in-person treatment." American 
Journal of Psychiatry 161(8): 1471-1476. 
Study outcomes  
9 Tse, S., et al. (2013). "Face-to-Face and Telephone Counseling for Problem 
Gambling: A Pragmatic Multisite Randomized Study." Research on Social Work 
Practice 23(1): 57-65. 
Study outcomes  
Initial search 
10 Cartwright, M., et al. (2013). "Effect of telehealth on quality of life and 
psychological outcomes over 12 months (Whole Systems Demonstrator 
telehealth questionnaire study): nested study of patient reported outcomes in 
a pragmatic, cluster randomised controlled trial." Bmj 346: f653. 
Study intervention 
11 Hirani, S. P., et al. (2014). "The effect of telecare on the quality of life and 
psychological well-being of elderly recipients of social care over a 12-month 




12 Robillard, G., et al. (2017). "Efficacy of telepsychotherapy for generalized 
anxiety disorder. Final results at the 6 month follow-up." Journal of Cyber 
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